User profiles for Andrew T. Yan
 | Andrew T. YanSt Michael's Hospital, University of Toronto Verified email at smh.ca Cited by 13446 |
Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post–myocardial infarction mortality
AT Yan, AJ Shayne, KA Brown, SN Gupta, CW Chan… - Circulation, 2006 - Am Heart Assoc
Background— Accurate risk stratification is crucial for effective treatment planning after
myocardial infarction (MI). Previous studies suggest that the peri-infarct border zone may be an …
myocardial infarction (MI). Previous studies suggest that the peri-infarct border zone may be an …
Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART CardioLink-6 randomized …
Background: SGLT2 (sodium-glucose cotransporter 2) inhibitors lower cardiovascular events
in type 2 diabetes mellitus but whether they promote direct cardiac effects remains unknown…
in type 2 diabetes mellitus but whether they promote direct cardiac effects remains unknown…
Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better
AT Yan, RT Yan, M Tan, A Casanova… - European heart …, 2007 - academic.oup.com
Aims Our objectives were (i) to compare the discriminatory performance of the Thrombolysis
in Myocardial Infarction risk score (TIMI RS), Platelet glycoprotein IIb/IIIa in Unstable angina: …
in Myocardial Infarction risk score (TIMI RS), Platelet glycoprotein IIb/IIIa in Unstable angina: …
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada
B Elbarouni, SG Goodman, RT Yan, RC Welsh… - American heart …, 2009 - Elsevier
BACKGROUND: The Global Registry of Acute Coronary Event (GRACE) risk score was
developed in a large multinational registry to predict in-hospital mortality across the broad …
developed in a large multinational registry to predict in-hospital mortality across the broad …
Effect of empagliflozin on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes mellitus and coronary artery disease
A, EPO levels in patients receiving empagliflozin 10 mg daily (red circles) or placebo (blue
squares) plotted as mean±95% CIs. Adjusted differences are betweengroup differences in …
squares) plotted as mean±95% CIs. Adjusted differences are betweengroup differences in …
Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes
S Poon, SG Goodman, RT Yan, R Bugiardini… - American heart …, 2012 - Elsevier
BACKGROUND: The question of whether gender-related disparities still exist in the treatment
and outcomes of patients presenting with acute coronary syndromes (ACS) remains …
and outcomes of patients presenting with acute coronary syndromes (ACS) remains …
The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary …
SG Goodman, W Huang, AT Yan, A Budaj… - American heart …, 2009 - Elsevier
BACKGROUND: The Global Registry of Acute Coronary Events (GRACE)—a prospective,
multinational study of patients hospitalized with acute coronary syndromes (ACSs)—was …
multinational study of patients hospitalized with acute coronary syndromes (ACSs)—was …
Effect of empagliflozin on left ventricular mass and diastolic function in individuals with diabetes: an important clue to the EMPA-REG OUTCOME trial?
Amid the excitement over the results of the BI 10773 (Empagliflozin) Cardiovascular Outcome
Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME) trial (1), the …
Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME) trial (1), the …
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the …
Background After acute coronary syndrome, diabetes conveys an excess risk of ischaemic
cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with ezetimibe …
cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with ezetimibe …
Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study
Background : Few longitudinal studies have delineated the association between traditional
cardiovascular risk factors and development of aortic stenosis (AS). Objectives : The authors …
cardiovascular risk factors and development of aortic stenosis (AS). Objectives : The authors …